Stock Market News3 days Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha
Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested.
Jim Cramer · Pharmaceuticals · Vertex (VRTX)
X7 hours Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha
X8 hours Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks
X1 day Jim Cramer talks being cautious with nuclear power and quantum computing stocks YouTube
X1 day Jim Cramer talks companies investors should be cautious of in 2025 YouTube
X1 day Lightning Round: Uber is down way too much, says Jim Cramer YouTube
X1 day Jim Cramer talks what 2025 has in store for stocks YouTube
X1 day Being a bear is easy in this business, says Jim Cramer YouTube
X1 day Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential Yahoo Finance
X2 days Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness Seeking Alpha
X2 days Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks
X2 days Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? Zacks
X2 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks
X3 days Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks
X3 days Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks
X3 days Here’s Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock Zacks
X4 days Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ Yahoo Finance
X4 days Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Yahoo Finance
X4 days Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital Yahoo Finance
X4 days Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring Seeking Alpha
X4 days Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock? Zacks
X4 days Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents Seeking Alpha
X1 week Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market Yahoo Finance
X1 week Telix Pharmaceuticals: Australian Company And A Solid Recent U.S. IPO Seeking Alpha
X1 week Stocks Hold In Quiet Day; Burlington Stores, Boston Scientific, Vertex Inc. In Focus Yahoo Finance
X1 week All You Need to Know About ANI (ANIP) Rating Upgrade to Buy Zacks
X1 week How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily
X1 week The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex Zacks
X1 week The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks
X1 week Is Vertex (VERX) a Solid Growth Stock? 3 Reasons to Think “Yes” Zacks
X1 week NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here’s Why Zacks
X1 week Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha
X1 week Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks
X1 week Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks
X1 week Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks
X1 week Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist Yahoo Finance
X1 week Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Yahoo Finance
X2 weeks Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks
X2 weeks Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha
X2 weeks Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks
X2 weeks Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha
X2 weeks Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks
X2 weeks Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance
X2 weeks Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance
X2 weeks Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily
X2 weeks Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com
X2 weeks Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance
X2 weeks Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha
X2 weeks VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks
X2 weeks Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube
X2 weeks Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.